MYLAN PHARMS INC FDA Approval ANDA 078922

ANDA 078922

MYLAN PHARMS INC

FDA Drug Application

Application #078922

Documents

Letter2008-02-19

Application Sponsors

ANDA 078922MYLAN PHARMS INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL300MG0ZIDOVUDINEZIDOVUDINE

FDA Submissions

ORIG1AP2008-02-14
LABELING; LabelingSUPPL4AP2011-03-02
LABELING; LabelingSUPPL5AP2012-03-30
LABELING; LabelingSUPPL9AP2015-06-26STANDARD
LABELING; LabelingSUPPL10AP2015-06-26STANDARD

Submissions Property Types

ORIG1Null1
SUPPL4Null1
SUPPL5Null15
SUPPL9Null7
SUPPL10Null7

TE Codes

001PrescriptionAB

CDER Filings

MYLAN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78922
            [companyName] => MYLAN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ZIDOVUDINE","activeIngredients":"ZIDOVUDINE","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ZIDOVUDINE","submission":"ZIDOVUDINE","actionType":"300MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.